Aprogen Healthcare & Games Inc (109960) - Total Liabilities
Based on the latest financial reports, Aprogen Healthcare & Games Inc (109960) has total liabilities worth ₩15.37 Billion KRW (≈ $10.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Aprogen Healthcare & Games Inc to assess how effectively this company generates cash.
Aprogen Healthcare & Games Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Aprogen Healthcare & Games Inc's total liabilities have evolved over time, based on quarterly financial data. Check 109960 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Aprogen Healthcare & Games Inc Competitors by Total Liabilities
The table below lists competitors of Aprogen Healthcare & Games Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hanil Chemical Ind. Co. Ltd
KQ:007770
|
Korea | ₩37.35 Billion |
|
MDB Capital Holdings, LLC Class A common
NASDAQ:MDBH
|
USA | $3.16 Million |
|
Dignitana AB
ST:DIGN
|
Sweden | Skr24.80 Million |
|
Grid Metals Corp
V:GRDM
|
Canada | CA$517.19K |
|
Samjin LND Co. Ltd
KQ:054090
|
Korea | ₩93.90 Billion |
|
Urteste SA
WAR:URT
|
Poland | zł19.10 Million |
|
Dunelm Group PLC
LSE:DNLM
|
UK | GBX622.70 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Aprogen Healthcare & Games Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 109960 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aprogen Healthcare & Games Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aprogen Healthcare & Games Inc (2013–2024)
The table below shows the annual total liabilities of Aprogen Healthcare & Games Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩33.08 Billion ≈ $22.42 Million |
+12.94% |
| 2023-12-31 | ₩29.29 Billion ≈ $19.85 Million |
+101.92% |
| 2022-12-31 | ₩14.51 Billion ≈ $9.83 Million |
+251.58% |
| 2021-12-31 | ₩4.13 Billion ≈ $2.80 Million |
-18.44% |
| 2020-12-31 | ₩5.06 Billion ≈ $3.43 Million |
-35.68% |
| 2019-12-31 | ₩7.87 Billion ≈ $5.33 Million |
-61.58% |
| 2018-12-31 | ₩20.47 Billion ≈ $13.87 Million |
-24.01% |
| 2017-12-31 | ₩26.94 Billion ≈ $18.26 Million |
+286.60% |
| 2016-12-31 | ₩6.97 Billion ≈ $4.72 Million |
-42.09% |
| 2015-12-31 | ₩12.03 Billion ≈ $8.15 Million |
+56.12% |
| 2013-12-31 | ₩7.71 Billion ≈ $5.22 Million |
-- |
About Aprogen Healthcare & Games Inc
Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more